Hot Heal Care Stocks To Own For 2014

With an average of 1.8 million homes on the market on any given day in the second quarter of 2013, home list prices are rising in major metro markets around the nation as housing inventory continues shrinking, but the city of Detroit, which filed for bankruptcy last month, is that one surprising dark horse among the Top 10 of Realtor.com's Turnaround Towns Report. With a median list price up by 37.8 percent, Detroit is second only to Oakland, Calif., where the median list price rose 41.3 percent. And in Detroit, the rate as which homes in this category are selling beats out every single town east of the Rockies. "Detroit has made remarkable progress in the last year, shrinking its inventory of unsold homes by more than 26 percent and becoming one of the most balanced markets in the nation," said Steve Berkowitz, CEO of Move, which operates Realtor.com. However, despite it's progress, Detroit ranks No. 7 overall on this list of the top turnaround towns. See if you can guess which towns made up the other nine, and then test your answers against the slideshow below. Hint: No town in Florida made the list this quarter. TOP 10 TURNAROUND TOWNS:

Top India Stocks To Watch For 2015: InterDigital Inc.(IDCC)

Interdigital, Inc. engages in the design and development of digital wireless technology solutions. The company offers technology solutions for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, and IEEE 802-related products and networks. It holds patents related to the fundamental technologies that enable wireless communications. The company licenses its patents to equipment producers that manufacture, use, and sell digital cellular and IEEE 802-related products; and licenses or sells mobile broadband modem solutions, including modem IP, know-how, and reference platforms to mobile device manufacturers, semiconductor companies, and other equipment producers that manufacture, use, and sell digital cellular products. InterDigital?s solutions are incorporated in various products comprising mobile devices, such as cellular phones, tablets, notebook computers, and wireless personal digital assistants; wireless infrastructure equipment, such as base stations; and components, dongles, and modules for wireless devices. The company was founded in 1972 and is headquartered in King of Prussia, Pennsylvania.

Advisors' Opinion:

• [By Eric Volkman]

  InterDigital (NASDAQ: IDCC  ) is about to raise its global profile following an international patent licensing deal. The company announced that it has entered an agreement with Spain-based Teltronic Unipersonal for the latter to license a set of its 4G technologies. The terms of the arrangement were not disclosed.

• [By James E. Brumley]

  When traders think of an IP (intellectual property) company, they tend to conjure up names like InterDigital, Inc. (NASDAQ:IDCC), VirnetX Holding Corporation (NYSEMKT:VHC), or of course, the well-known Vringo, Inc. (NASDAQ:VRNG). And, investors see these patent-enforcement names as such for good reason.... between VRNG, IDCC, and VHC, the three organizations own well over 20,000 technology patents, and their efforts to enforce them have been well-documented, and well publicized. Thing is, as the patent-protection industry matures, companies like Vringo, InterDigital, or VirnetX Holding may well find that it's the quality of the patent portfolio rather than the quantity of patents that makes an IP owner a potent investment. Enter Endeavor IP Inc. (OTCBB:ENIP).

Hot Heal Care Stocks To Own For 2014: AbbVie Inc (ABBV)

AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products.

AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.

Advisors' Opinion:

• [By Brian Orelli]

  That's true of rheumatoid arthritis, which has multiple blockbuster drugs serving patients. Pfizer's hoping that its oral medication, Xeljanz, can take down the current offerings, including Johnson & Johnson's Remicade, AbbVie's (NYSE: ABBV  ) Humira, and Enbrel, sold by Pfizer and Amgen (NASDAQ: AMGN  ) , which all have to be injected. It'll take awhile to capture sales from drugs that doctors are comfortable prescribing, but investors will be happy with just a fraction of the market -- Remicade topped $6 billion last year, Enbrel broke $4 billion, and Humira topped the list at $9.3 billion.

• [By Shauna O'Brien]

  On Tuesday, AbbVie Inc (ABBV) released phase III results from the SAPPHIRE-II study, which is the second of six phase 3 studies for the treatment of the hepatitis C virus (HCV) genotype 1 (GT1) infection.

  AbbVie reported that in the study, which included 394 patients, 96% of those who has previously failed pegylated interferon and ribavirin treatment in the past sustained virologic response at 12 weeks with the regimen.

  There are 160 million infected with hepatitis C worldwide. ABBV’s HCV program is currently the largest all oral, interferon-free clinical program in GT1 patients being conducted.

  AbbVie shares were mostly flat during Tuesday morning trading. The stock is up 50% YTD.

• [By Dimitra DeFotis]

  Here are insights on the conference call that ensued, from�ISI’s biotech and pharmaceutical industry analyst�Mark Schoenbaum,�paraphrased:

  Merck wants “bolt-ons” acquisitions (like Idenix Pharmaceuticals (IDIX)) versus big purchases. Moreover, it is not interested in a deal primarily or solely for tax inversion purposes … �[That's not ruling out the possibility of buying a foreign company to avoid U.S. taxes, but the language seems contrary to the foreign-merger possibilities for other healthcare companies, including�Valeant Pharmaceuticals (VRX), Actavis (ACT), Pfizer (PFE), AbbVie (ABBV), Medtronic (MDT) and even�Walgreen (WAG).] Merck sees a “high likelihood” of success for the four-week Hepatitis C regimen from C-SWIFT when presented at a medical conference this fall. (The combo treatment includes Gilead’s Sovaldi, already on the market, and a Merck regimen.) The company sees “lots of opportunities” to possibly accelerate Food & Drug Administration filings for an experimental immuno-oncology drug for lung cancer patients. It’s excited about the expected Aug. 14 FDA decision on insomnia drug Suvorexant. (Wall Street is bearish on commercial prospects.) Merck expects U.S. volume growth for diabetes drug Januvia (which is roughly 25% of earnings) in the second half of 2014.

  For healthcare investing ideas and insight on so-called tax inversions, see the Barrons.com Q&A with Andy Acker, manager of the Janus Global Life Sciences Fund (JAGLX): “Undervalued Biotech Stocks Help Fund Beat the Index,” July 29. (Subscription required) One insight from Acker:

• [By Dan Carroll]

  Abbott Labs'� (NYSE: ABT  ) stock has surged this year, shooting up more than 15% since the start of 2013. Despite the company's spinoff of former pharmaceutical firm AbbVie (NYSE: ABBV  ) �-- a move that waved goodbye to its high-growth pharmaceuticals business, including massive immunology blockbuster Humira that pulled in $9 billion in sales last year -- Abbott has still managed to find growth by turning to a new engine: emerging markets.

Hot Heal Care Stocks To Own For 2014: Anheuser-Busch InBev (BUD)

Anheuser-Busch InBev SA/NV, incorporated on August 2, 1977, is a brewing company. The Company produces, markets, distributes and sells a balanced portfolio of approximately 200 beer brands. These include global flagship brands Budweiser, Stella Artois and Beck��; multi-country brands, such as Leffe and Hoegaarden, and many local champions, such as Bud Light, Skol, Brahma, Quilmes, Michelob, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske and Jupiler. The Company also produces and distributes soft drinks, particularly in Latin America. The Company operates in seven segments: North America, Latin America North, Latin America South, Western Europe, Central & Eastern Europe, Asia Pacific and Global Export & Holding Companies. On October 20, 2010, Companhia de Bebidas das Americas-AmBev (AmBev) and Cerveceria Regional S.A. closed a transaction pursuant, to which they combined their businesses in Venezuela, with Regional owning an 85% interest and AmBev owning the remaining 15% in the new company. On February 28, 2011, the Company closed a transaction with Dalian Daxue Group Co., Ltd and Kirin (China) Investment Co., Ltd to acquire a 100% equity interest in Liaoning Dalian Daxue Brewery Co., Ltd. The Company�� beer portfolio is divided into global, multi-country and local brands. Beer can be differentiated into the categories, such as premium brands; mainstream or core brands, and value, discount or sub-premium brands. The Company also has a presence in the soft drink market in Latin America through its subsidiary AmBev and in the United States through Anheuser-Busch Companies, Inc. (Anheuser-Busch). Soft drinks include both carbonated soft and non-carbonated soft drinks. Its soft drinks business includes both its own production and agreements with PepsiCo related to bottling and distribution. The brands that are distributed under these agreements are Pepsi, 7UP and Gatorade. AmBev has long-term agreements with PepsiCo whereby AmBev has the exclusive right to bottle, sell and distribute certain brands of PepsiCo�� portfolio of carbonated soft drinks in Brazil. In the United States, Anheuser-Busch also produces non-alcoholic malt beverage products, including O��oul�� and O��oul�� Amber, energy drinks and related products. In the United States, its indirect subsidiary, Metal Container Corporation, manufactures beverage cans at eight plants and beverage can lids at three plants for sale to its Anheuser-Busch beer operations and United States soft drink customers. Anheuser-Busch also owns a recycling business, which buys and sells used beverage containers and recycles aluminum and plastic containers; a manufacturer of crown liner materials for sale to its North American beer operations, and a glass manufacturing plant which manufactures glass bottles for use by its North American beer operations. Advisors' Opinion:

• [By Taylor Muckerman and Joel South]

  Much like the wine industry in California, Anheuser-Busch InBev (NYSE: BUD  ) has made its opposition to hydraulic fracturing for natural gas in Germany well known. Due to purity laws dating back to the 1500s, German brewers are worried about the contamination of their water sources, which must remain absent of any unnatural additives.�

• [By Matt Basil]

  Let's start with�Anheuser-Busch InBev (NYSE: BUD  ) . According to its accounting, A-B InBev controlled 47.2% of the U.S. market share in December 2013. That is impressive, considering there are over 2,700 breweries in the United States. Bud's strength is derived primarily from two of the most recognizable brands in the country: the classic Budweiser, which, according to Beer Marketer's INSIGHTS, accounted for 8.4% of the U.S. beer market share in 2012, and his cash cow of a brother, Bud Light. In 2012, Bud Light commanded 18.5% of the domestic beer market; more than double that of the nearest competitor, Coors Light. Even college favorite Natural Light made the top five individual brands with 3.7%. In all, it's a market share fitting the King of Beers.

• [By Charles Sizemore]

  In mid-February of last year, Anheuser-Busch Inbev (BUD) acquired Mexican brewer Grupo Modelo, the maker of the Corona and Negro Modelo brands, but as part of the deal, BUD had to sell the distribution rights via its stake in Crown Imports in order to keep the regulators happy.

Hot Heal Care Stocks To Own For 2014: WisdomTree SmallCap Earnings Fund (EES)

WisdomTree SmallCap Earnings Fund (the Fund) seeks investment results that correspond to the price and yield performance of the WisdomTree SmallCap Earnings Index (the Index). The Index is a fundamentally weighted index that measures the performance of earnings-generating companies within the small-capitalization segment of the United States stock market. The Index consists of the companies in the bottom 25% of the market capitalization of the WisdomTree Earnings Index after the 500 largest companies have been removed. Companies must be incorporated and listed in the United States, and must have generated positive cumulative earnings over their most recent four fiscal quarters prior to the Index measurement date. The Index is earnings-weighted in December to reflect the proportionate share of the aggregate earnings each component company has generated. Companies with greater earnings generally have larger weights in the Index. Its investment advisor is WisdomTree Asset Management, Inc. Advisors' Opinion:

• [By Philip Springer]

  WisdomTree SmallCap Earnings Fund (EES) follows earnings generated by companies in the small-cap universe of the US stock market.

  Furthermore, the fund looks to weight by earnings, giving bigger weights to firms that earn more, irrespective of market capitalization.

Hot Heal Care Stocks To Own For 2014: Drinks Americas Holdings Ltd (DKAM)

Drinks Americas Holdings, Ltd., incorporated in February 14, 2005, develops, produces, markets and/or distributes alcoholic and non-alcoholic beverages for sale primarily in the continental United States. Through its majority-owned subsidiaries, Drinks imports, distributes and markets premium wine and spirits and alcoholic beverages to beverage wholesalers throughout the United States and internationally. The alcoholic products distributed by the Company are KAH Tequila, Old Whiskey River Bourbon (R), Rheingold Beer, Damiana, a Mexican liqueur, Mexicali Beer, Agave 99, Chili Devil Beer, Crazy PigAle and Red Pig Ale. In June, 2011 the Company acquired the rights to distribute and market existing brands and products from Fabrica De Tequilas Finos S.A. de C.V. (Finos) and Cervecera Mexicana, S. de R.L. de C.V. (Cerveceria). In June 2011, the Company acquired the rights to distribute and market existing brands and products through a licensing agreement with Worldwide Beverage Imports, LLC, (WBI). On November 2, 2011, the Company acquired worldwide licensing and distribution rights on both the spirits and beer products owned or licensed by WBI. In June 2013, the Company announced the development of Drinks Americas Consumer Beverage Consulting Division.

The Company owns, distributes or licenses or collects royalties from a number of Spirits Brands to include Old Whiskey River Bourbon, Damiana Liqueur and Rheingold Beer. The Company owns 25% interest in Old Whiskey River Distilling Company, LLC which owns or licenses the related trademarks and trade names associated with the Old Whiskey River products.

The Company compets with Diageo, Allied Domecq, Pernod Ricard, Brown-Forman and Bacardi & Company, Ltd.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Drinks Americas Holdings, Ltd (OTCMKTS: DKAM), 7 Star Entertainment Inc (OTCMKTS: SAEE), Rising India Inc (OTCMKTS: RSII) and Big Tree Group Inc (OTCMKTS: BIGG) have all been attracting attention thanks to paid promotions. Of course, there is nothing wrong with properly disclosed and paid for promotions or investor relation activities, but they can backfire on unwary investors and traders alike. So are stock promoters blowing a bunch of hot air regarding these four small cap stocks or are they actually potential winners? Here is a quick reality check to help you decide:

  Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) Has One of the Top Beers of 2013

  Small cap Drinks Americas Holdings mission is to identify and invest the majority brand-building resources on beers and spirits with the greatest growth potential. Currently, Drinks Americas is the exclusive United States broker for leading premium authentic Mexican beers currently available in over 32 states, hundreds of chain retailers and restaurants and is on target to be the leading broker for this growing category in each of the markets in which it operates. On Friday, Drinks Americas Holdings rose 2.15% to $0.0095 for a market cap of $280,110 plus DKAM is down 89.3% over the past year and down 94.6% over the past five years according to Google Finance.

• [By Peter Graham]

  Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

• [By Bryan Murphy]

  Say whatever you want about Drinks Americas Holdings, Ltd. (OTCMKTS:DKAM), but one thing is undeniable... this company is producing a lot of revenue despite being a very small company. More specifically, the DKAM market cap is abnormally low relative to the sales figures the company is putting up.

• [By Bryan Murphy]

  Even though you're reading this now, odds are that three weeks ago you'd never even heard of Drinks Americas Holdings, Ltd. (OTCMKTS:DKAM). And, like so many other young, nano-cap stocks, it would be easy to assume the current strength being exhibited by DKAM is nothing but a short-term phenomenon, meaning there's no particular reason to jump on the stock now. If there was ever a reason to jump onto a micro cap name for a quick trade though, this may be it.

Hot Heal Care Stocks To Own For 2014: Skechers U.S.A. Inc.(SKX)

Skechers U.S.A., Inc. engages in the design, development, marketing, and distribution of footwear for men, women, and children in the United States and internationally. The company offers various products comprising casuals, such as boots, shoes, and sandals for men, as well as slip-ons, lug outsole and fashion boots, and casual sandals for women; dress casuals; relaxed fit for men; sandals; and casual fusion under the Skechers USA brand name. It also provides a line of sport footwear for men and women, including men?s lifestyle athletic footwear, lightweight women?s sneakers, and sport sandals under the Skechers Sport brand name. In addition, the company offers men?s and women?s casuals, field boots, hikers, and athletic shoes under the Skechers Work brand name; and a range of infants, toddlers, boys, and girls? boots, shoes, and sneakers under the Skechers Kids brand name. Further, its product line includes Skechers Active products, such as casual everyday and sport fusi on sneakers for females; Tone-ups and Tone-ups Fitness products comprising casual and athletic-inspired sandals for women, as well as sneakers; Shape-ups toning footwear for men and women; and Skechers Resistance Runner technical shoes for runners. Skechers U.S.A. markets its products through department and specialty stores, athletic and independent retailers, and boutiques, catalog and Internet retailers, as well as through own e-commerce Website and retail stores. As of February 15, 2011, it operated 105 concept stores, 99 factory outlet stores, and 40 warehouse outlet stores in the United States, as well as 28 concept stores and 16 factory outlets internationally. The company was founded in 1992 and is headquartered in Manhattan Beach, California.

Advisors' Opinion:

• [By Monica Gerson]

  Skechers USA (NYSE: SKX) is expected to post its Q3 earnings at $0.61 per share on revenue of $518.22 million.

  Terex (NYSE: TEX) is estimated to post its Q3 earnings at $0.59 per share on revenue of $1.95 billion.

• [By Ben Levisohn]

  Shares of Nike have dropped 1.2% to $77.33 today at 3:19 p.m., even as Under Armour (UA) has risen 1.3% to $87.16 and Skechers U.S.A. (SKX) has gained 1.9% to $33.06. Even Lululemon Athletica (LULU), which has dropped 16% in December, has ticked up today–it’s gained 0.1% to $58.83.

• [By Suravi Thacker]

  Macroeconomic conditions have been quite harsh on retailers. Factors such as severe weather conditions and a shift in Easter have kept customers away from malls and other retail stores, resulting in loss of sales. As a result, footwear retailers have posted dismal results for the holiday quarter. However, there is an exception to this. Skechers USA (SKX) has been a great performer and its holiday quarter delivered strong numbers, bucking the industry wide trend. Its results beat analysts��expectations, leading to a sharp increase in its stock price.

• [By alicet236]

  Skechers USA(SKX): CEO, 10% Owner Robert Greenberg sold 300,000 Shares

  CEO, 10% Owner of Skechers USA (SKX) Robert Greenberg sold 300,000 shares on Dec. 19 at an average price of $33.08. Skechers USA was incorporated in California in 1992 and reincorporated in Delaware in 1999. Skechers Usa has a market cap of $1.69 billion; its shares were traded at around $33.23 with a P/E ratio of 37.80 and P/S ratio of 0.90.